BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38109897)

  • 1. Liver metastases of neuroendocrine tumors: Conventional transarterial chemoembolization and thermal ablation.
    Vogl TJ; Gruber-Rouh T; Naguib NNN; Lingwal N; Bolik P
    Rofo; 2024 Apr; 196(4):381-389. PubMed ID: 38109897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventional oncological treatment of breast cancer liver metastasis (BCLM): single center long-term evaluation over 26 years using thermoablation techniques like LITT, MWA and TACE in a multimodal application.
    Vogl TJ; Freichel J; Gruber-Rouh T; Nour Eldin NE; Becker S; Solbach C; Stefenelli U; Naguib NNN
    Int J Hyperthermia; 2023; 40(1):2200582. PubMed ID: 37121606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventional oncological treatment of hepatocellular carcinoma (HCC) - A single-center long-term evaluation of thermoablation techniques like LITT, MWA, and TACE in a multimodal application over 26 years.
    Vogl TJ; Freichel J; Gruber-Rouh T; Nour-Eldin Abdelrehim NE; Bechstein WO; Zeuzem S; Naguib NNN; Stefenelli U
    Heliyon; 2023 Apr; 9(4):e14646. PubMed ID: 37009241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thermal Ablation of Colorectal Lung Metastases: Retrospective Comparison Among Laser-Induced Thermotherapy, Radiofrequency Ablation, and Microwave Ablation.
    Vogl TJ; Eckert R; Naguib NN; Beeres M; Gruber-Rouh T; Nour-Eldin NA
    AJR Am J Roentgenol; 2016 Dec; 207(6):1340-1349. PubMed ID: 27680945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits of step-by-step debulking microwave ablation for huge unresectable hepatocellular carcinoma patients after transcatheter arterial chemoembolization refractoriness.
    Huang T; Qi H; Shen L; Wu Y; Song Z; Cao F; Liu Y; Xie L; Chen S; Tang T; Li H; Zhang Y; Feng L; Zhang H; Chen J; Fan W
    Int J Hyperthermia; 2022; 39(1):935-945. PubMed ID: 35853727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant TACE before laser induced thermotherapy (LITT) in the treatment of non-colorectal non-breast cancer liver metastases: feasibility and survival rates.
    Vogl TJ; Kreutzträger M; Gruber-Rouh T; Eichler K; Nour-Eldin NE; Zangos S; Naguib NN
    Eur J Radiol; 2014 Oct; 83(10):1804-10. PubMed ID: 25082479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the Efficacy and Prognostic Factors of Transarterial Chemoembolization Plus Microwave Ablation versus Transarterial Chemoembolization Alone in Patients with a Large Solitary or Multinodular Hepatocellular Carcinomas.
    Zheng L; Li HL; Guo CY; Luo SX
    Korean J Radiol; 2018; 19(2):237-246. PubMed ID: 29520181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ablation therapy of non-colorectal cancer lung metastases: retrospective analysis of tumour response post-laser-induced interstitial thermotherapy (LITT), radiofrequency ablation (RFA) and microwave ablation (MWA).
    Nour-Eldin NA; Exner S; Al-Subhi M; Naguib NNN; Kaltenbach B; Roman A; Vogl TJ
    Int J Hyperthermia; 2017 Nov; 33(7):820-829. PubMed ID: 28540791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transarterial Chemoembolization Monotherapy Versus Combined Transarterial Chemoembolization-Microwave Ablation Therapy for Hepatocellular Carcinoma Tumors ≤5 cm: A Propensity Analysis at a Single Center.
    Chen QF; Jia ZY; Yang ZQ; Fan WL; Shi HB
    Cardiovasc Intervent Radiol; 2017 Nov; 40(11):1748-1755. PubMed ID: 28681222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transarterial chemoembolization combined with microwave ablation and apatinib in patients with Barcelona clinic liver cancer Stage C hepatocellular carcinoma: A propensity score matching analysis.
    Shuanggang C; Shen L; Qiu Z; Qi H; Cao F; Xie L; Fan W
    J Cancer Res Ther; 2020; 16(2):250-257. PubMed ID: 32474509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination transarterial chemoembolization and microwave ablation improves local tumor control for 3- to 5-cm hepatocellular carcinoma when compared with transarterial chemoembolization alone.
    Smolock AR; Cristescu MM; Hinshaw A; Woo KM; Wells SA; Ziemlewicz TJ; Lubner MG; Dalvie PS; Louis Hinshaw J; Brace CL; Ozkan OS; Lee FT; Laeseke P
    Abdom Radiol (NY); 2018 Sep; 43(9):2497-2504. PubMed ID: 29450606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver metastases: neoadjuvant downsizing with transarterial chemoembolization before laser-induced thermotherapy.
    Vogl TJ; Mack MG; Balzer JO; Engelmann K; Straub R; Eichler K; Woitaschek D; Zangos S
    Radiology; 2003 Nov; 229(2):457-64. PubMed ID: 14500854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nomogram to predict survival of patients with intermediate-stage hepatocellular carcinoma after transarterial chemoembolization combined with microwave ablation.
    Ni JY; Fang ZT; Sun HL; An C; Huang ZM; Zhang TQ; Jiang XY; Chen YT; Xu LF; Huang JH
    Eur Radiol; 2020 Apr; 30(4):2377-2390. PubMed ID: 31900694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival of patients with non-resectable, chemotherapy-resistant colorectal cancer liver metastases undergoing conventional lipiodol-based transarterial chemoembolization (cTACE) palliatively versus neoadjuvantly prior to percutaneous thermal ablation.
    Vogl TJ; Lahrsow M; Albrecht MH; Hammerstingl R; Thompson ZM; Gruber-Rouh T
    Eur J Radiol; 2018 May; 102():138-145. PubMed ID: 29685527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined transarterial chemoembolization and microwave ablation versus transarterial chemoembolization in BCLC stage B hepatocellular carcinoma.
    Zhang R; Shen L; Zhao L; Guan Z; Chen Q; Li W
    Diagn Interv Radiol; 2018 Jul; 24(4):219-224. PubMed ID: 29792289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transarterial chemoembolization combined with microwave ablation versus microwave ablation only for Barcelona clinic liver cancer Stage B hepatocellular carcinoma: A propensity score matching study.
    Li X; Chen B; An C; Cheng Z; Han Z; Liu F; Yu J; Liang P
    J Cancer Res Ther; 2020 Sep; 16(5):1027-1037. PubMed ID: 33004744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microwave ablation and synchronous transarterial chemoembolization combined with PD-1 inhibitor in patients with hepatocellular carcinoma following tyrosine kinase inhibitor intolerance.
    Shi Q; Zhou X; Zhang Z; Zhang W; Ma J; Yang M; Yu J; Luo J; Liu L; Yan Z
    Front Immunol; 2022; 13():1097625. PubMed ID: 36703965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microwave ablation combined with lipiodol-microsphere mixed or conventional transarterial chemoembolization for the treatment of colorectal liver metastases: A retrospective study.
    Shi Q; Wang F; Du N; Zhou Y; Zhou X; Ma J; Yang M; Zhang Z; Yu J; Zhang W; Luo J; Liu L; Yan Z
    Clin Res Hepatol Gastroenterol; 2022; 46(7):101986. PubMed ID: 35772684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous Thermal Ablation Therapy of Hepatocellular Carcinoma (HCC): Microwave Ablation (MWA) versus Laser-Induced Thermotherapy (LITT).
    Adwan H; Vogl TJ; Balaban Ü; Nour-Eldin NA
    Diagnostics (Basel); 2022 Feb; 12(3):. PubMed ID: 35328117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transarterial Chemoembolization and Sorafenib Combined with Microwave Ablation for Advanced Primary Hepatocellular Carcinoma: A Preliminary Investigation of Safety and Efficacy.
    Ni JY; Sun HL; Luo JH; Jiang XY; Chen D; Wang WD; Chen YT; Huang JH; Xu LF
    Cancer Manag Res; 2019; 11():9939-9950. PubMed ID: 32063720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.